So I need to understand SK sentiment before we have a new CEO in place; what is downside of have SK on the BOD, what is sinister exactly about him? We should have a discussion about Board structure and not just knee jerk reactions. I would say he probably was the push for NP's departure. He might be kind of holding things together calling us an oncology company, so what specifics don't people like?